Search

Search Constraints

You searched for: Author/Creator Bojja, Kumar

Search Results

1. 0120 SUVN-G3031, a Novel, Potent and Selective Histamine H3 Receptor Inverse Agonist for the Treatment of Narcolepsy: Preclinical Characterization. (12th April 2019)

2. 0265 Samelisant (SUVN-G3031), a Histamine H3 Receptor Inverse Agonist in Animal Models of Narcolepsy. (25th May 2022)

3. 1‐[2‐(1‐Cyclobutylpiperidin‐4‐yloxy)‐6, 7‐dihydro‐4H‐thiazolo[5, 4‐c]pyridin‐5‐yl]propan‐1‐one: a Histamine H3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition. (18th November 2021)

4. P3‐042: SUVN‐502: A PURE 5‐HT6 ANTAGONIST POTENTIATES THE EFFECTS OF DONEPEZIL OR MEMANTINE IN ANIMAL MODELS OF COGNITION, NEUROCHEMISTRY AND ELECTROPHYSIOLOGY. (1st July 2019)

5. SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits: Biomarkers (non‐neuroimaging)/Prognostic utility. (7th December 2020)